Does self-monitoring or self-management of oral anticoagulation therapy reduce thromboembolic events and mortality in patients on oral anticoagulation?
Self-monitoring and self-management of oral anticoagulation reduce thromboembolic events, and self-management additionally reduces all-cause mortality without increasing major hemorrhage.
Participants who self-monitor or self-manage can improve the quality of their oral anticoagulation therapy. Thromboembolic events were reduced, for both those self-monitoring or self-managing oral anticoagulation therapy. A reduction in all-cause mortality was observed in trials of self-management but not in self-monitoring, with no effects on major haemorrhage.
Heneghan et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: